Autologous stem-cell transplant plus rituximab for newly diagnosed mantle cell lymphoma: Up-date of a phase II trial

被引：0
|
作者：
Hicks, L
Mangel, J
Connors, J
Buckstein, R
Leitch, H
Imrie, K
Crump, M
Spaner, D
Pennell, N
Nagy, T
Boudreau, A
Berinstein, N
机构：
[1] Sunnybrook & Womens Coll Hosp, Toronto, ON, Canada
[2] London Hlth Sci Ctr, London, ON, Canada
[3] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[4] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
454
引用
收藏
页码：170 / 170
页数：1
相关论文
共 50 条
  • [41] Chop and DHAP plus rituximab followed by autologous stem cell transplantation (ASCT) in mantle cell lymphoma (MCL): A study from the gela
    Delarue, R
    Haioun, C
    Levy, V
    Ribrag, V
    Brice, P
    Tilly, H
    Salanoubat, C
    Delmer, A
    Van Hoof, A
    Casasnovas, O
    Lefrere, F
    Salles, G
    Brousse, N
    Hermine, O
    ANNALS OF ONCOLOGY, 2005, 16 : 96 - 96
  • [42] Interim Analysis of a Phase 2 Study of Bortezomib Plus Rituximab Maintenance Therapy in Patients with Mantle Cell Lymphoma Status Post Autologous Stem Cell Transplantation
    Chen, Robert
    Palmer, Joycelynne
    Holmberg, Leona
    Alluin, Jessica
    Chomchan, Pritsana
    Popplewell, Leslie L.
    Siddiqi, Tanya
    Thomas, Sandra H.
    Irenze, Kathryn
    Nademanee, Auayporn P.
    Spielberger, Ricardo
    Rossi, John J.
    Rosen, Steven T.
    Kwak, Larry W.
    Forman, Stephen J.
    BLOOD, 2015, 126 (23)
  • [43] Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
    Dreyling, Martin
    Doorduijn, Jeanette
    Gine, Eva
    Jerkeman, Mats
    Walewski, Jan
    Hutchings, Martin
    Mey, Ulrich
    Riise, Jon
    Trneny, Marek
    Vergote, Vibeke
    Shpilberg, Ofer
    da Silva, Maria Gomes
    Leppa, Sirpa
    Jiang, Linmiao
    Stilgenbauer, Stephan
    Kerkhoff, Andrea
    Jachimowicz, Ron
    Celli, Melania
    Hess, Georg
    Arcaini, Luca
    Visco, Carlo
    van Meerten, Tom
    Wirths, Stefan
    Zinzani, Pier Luigi
    Novak, Urban
    Herhaus, Peter
    Benedetti, Fabio
    Sonnevi, Kristina
    Hanoun, Christine
    Haenel, Matthias
    Dierlamm, Judith
    Pott, Christiane
    Klapper, Wolfram
    Goezel, Doendue
    Schmidt, Christian
    Unterhalt, Michael
    Ladetto, Marco
    Hoster, Eva
    LANCET, 2024, 403 (10441): : 2293 - 2306
  • [44] A Prospective Study of Rituximab/Bendamustine and Rituximab/DHAP plus /- Zanubrutinib Induction Therapy with or without ASCT in Young Newly Diagnosed Mantle Cell Lymphoma
    Wang, Hui
    Xing, Lijie
    Liu, Dan
    Wei, Haichen
    Lu, Ke
    He, Qiang
    Xie, Linna
    Ma, Ji
    Qiu, Lugui
    Li, Zengjun
    BLOOD, 2024, 144 : 6307 - 6308
  • [45] AUTOLOGOUS STEM CELL TRANSPLANTATION (HCT) WITH OR WITHOUT TOTAL BODY IRRADIATION (TBI) IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA (MCL) PATIENTS
    Szymczyk, M.
    Romejko-Jarosinska, J.
    Brzeska, B.
    Osiadacz, W.
    Domanska-Czyz, K.
    Smorczewska, M.
    Hermine, O.
    Dreyling, M. H.
    Walewski, J. A.
    ANNALS OF ONCOLOGY, 2012, 23 : 354 - 354
  • [46] Rituximab Plus Hypercvad Alternating with High Dose Methotrexate and Cytarabine for Patients with Newly Diagnosed Mantle Cell Lymphoma. A Multicenter Trial from GISL
    Merli, Francesco
    Luminari, Stefano
    Ilariucci, Fiorella
    Stelitano, Caterina
    Petrini, Mario
    Di Renzo, Nicola
    Angrilli, Francesco
    Carella, Angelo Michele
    Barbolini, Elisa
    Federico, Massimo
    BLOOD, 2008, 112 (11) : 1048 - 1049
  • [47] Quality of Life during Survivorship Following Autologous Stem Cell Transplant for Mantle Cell Lymphoma
    Di, Mengyang
    Ho, Carrie, I
    Smith, Stephen D.
    Shadman, Mazyar
    Ujjani, Chaitra S.
    Lynch, Ryan C.
    Poh, Christina
    Raghunathan, Vikram
    Till, Brian G.
    Warren, Edus H.
    Gopal, Ajay K.
    Lee, Stephanie J.
    BLOOD, 2024, 144 : 5116 - 5117
  • [48] High dose chemotherapy with autologous stem cell transplant (ASCT) for mantle cell lymphoma (MCL).
    Segota, E
    Pohlman, B
    Jin, T
    Kuczkowski, E
    Rybicki, L
    Kalaycio, M
    Sobecks, R
    Andresen, S
    Bolwell, U
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 602S - 602S
  • [49] Maintenance Rituximab Improves Outcomes in Mantle Cell Lymphoma Patients Who Respond to Induction Therapy with Bendamustine plus Rituximab without Autologous Transplant
    Hill, Brian T.
    Switchenko, Jeffrey M.
    Martin, Peter
    Churnetski, Michael C.
    Sawalha, Yazeed
    Goyal, Subir
    Shanmugasundaram, Krithika
    Calzada, Oscar
    Kolla, Bhaskar
    Bachanova, Veronika
    Gerson, James N.
    Barta, Stefan K.
    Gordon, Max J.
    Danilov, Alexey
    Grover, Natalie S.
    Mathews, Stephanie
    Burkart, Madelyn
    Karmali, Reem
    Ghosh, Nilanjan
    Park, Steven I.
    Epperla, Narendranath
    Bond, David A.
    Badar, Talha
    Blum, Kristie A.
    Guo, Jin
    Hamadani, Mehdi
    Fenske, Timothy S.
    Malecek, Mary-Kate
    Kahl, Brad S.
    Flowers, Christopher R.
    Cohen, Jonathon B.
    BLOOD, 2019, 134
  • [50] Immunochemotherapy and Autologous Stem-Cell Transplantation for Untreated Patients With Mantle-Cell Lymphoma: CALGB 59909
    Damon, Lloyd E.
    Johnson, Jeffrey L.
    Niedzwiecki, Donna
    Cheson, Bruce D.
    Hurd, David D.
    Bartlett, Nancy L.
    LaCasce, Ann S.
    Blum, Kristie A.
    Byrd, John C.
    Kelly, Michael
    Stock, Wendy
    Linker, Charles A.
    Canellos, George P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) : 6101 - 6108
12345